FTY720-induced Human Pulmonary Endothelial Barrier Enhancement is Mediated by C-Abl

Overview

Journal Eur Respir J

Specialty Pulmonary Medicine

Date 2010 Nov 13

PMID 21071472

Citations 41

Authors

L Wang

E T Chiang

J T Simmons

J G N Garcia

S M Dudek

Affiliations

Soon will be listed here.

Abstract

Strategies to improve pulmonary endothelial barrier function are needed to reverse the devastating effects of vascular leak in acute respiratory distress syndrome. FTY720 is a pharmaceutical analogue of the potent barrier-enhancing phospholipid sphingosine 1-phosphate (S1P). FTY720 decreases vascular permeability by an incompletely characterised mechanism that differs from S1P. Here, we describe its barrier-promoting effects on intracellular signalling and junctional assembly formation in human pulmonary endothelium. Permeability of cultured human pulmonary endothelial cells was assessed using transendothelial electrical resistance and dextran transwell assays. Junctional complex formation was assessed using membrane fractionation and immunofluorescence. Pharmacological inhibitors and small interfering (si)RNA were utilised to determine the effects of individual components on permeability. Unlike S1P, FTY720 failed to induce membrane translocation of adherens junction or tight junction proteins. β-catenin, occludin, claudin-5 or zona occludens protein (ZO)-1/ZO-2 siRNAs did not alter FTY720-induced barrier enhancement. FTY720 induced focal adhesion kinase (FAK) phosphorylation and focal adhesion formation, with FAK siRNA partially attenuating the prolonged phase of barrier enhancement. Inhibition of Src, protein kinase (PK)A, PKG, PKC or protein phosphatase 2A failed to alter FTY720-induced barrier enhancement. FTY720 increased c-Abl tyrosine kinase activity and c-Abl siRNA attenuated peak barrier enhancement after FTY720. FTY720 enhances endothelial barrier function by a novel pathway involving c-Abl signalling.

Citing Articles

Fingolimod, a sphingosine-1-phosphate receptor modulator, prevents neonatal bronchopulmonary dysplasia and subsequent airway remodeling in a murine model.

Sudhadevi T, Annadi A, Basa P, Jafri A, Natarajan V, Harijith A J Appl Physiol (1985). 2024; 137(5):1231-1242.

PMID: 39262336 PMC: 11563639. DOI: 10.1152/japplphysiol.00311.2024.

Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases.

Oltmanns F, Vieira Antao A, Irrgang P, Viherlehto V, Jorg L, Schmidt A J Immunother Cancer. 2024; 12(3).

PMID: 38458636 PMC: 10921546. DOI: 10.1136/jitc-2023-008652.

Lamellipodia dynamics and microrheology in endothelial cell paracellular gap closure.

Arce F, Younger S, A Gaber A, Mascarenhas J, Rodriguez M, Dudek S Biophys J. 2023; 122(24):4730-4747.

PMID: 37978804 PMC: 10754712. DOI: 10.1016/j.bpj.2023.11.016.

Glycolytic enzyme PFKFB3 regulates sphingosine 1-phosphate receptor 1 in proangiogenic glomerular endothelial cells under diabetic condition.

Yu B, Shen K, Li T, Li J, Meng M, Liu W Am J Physiol Cell Physiol. 2023; 325(5):C1354-C1368.

PMID: 37781737 PMC: 10861147. DOI: 10.1152/ajpcell.00261.2023.

Edema and lymphatic clearance: molecular mechanisms and ongoing challenges.

Breslin J Clin Sci (Lond). 2023; 137(18):1451-1476.

PMID: 37732545 PMC: 11025659. DOI: 10.1042/CS20220314.

References

Sun X, Shikata Y, Wang L, Ohmori K, Watanabe N, Wada J . Enhanced interaction between focal adhesion and adherens junction proteins: involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement. Microvasc Res. 2009; 77(3):304-13. PMC: 3136042. DOI: 10.1016/j.mvr.2008.12.004. View

Tsukita S, Furuse M, Itoh M . Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001; 2(4):285-93. DOI: 10.1038/35067088. View

Peng X, Hassoun P, Sammani S, McVerry B, Burne M, Rabb H . Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med. 2004; 169(11):1245-51. DOI: 10.1164/rccm.200309-1258OC. View

Van Itallie C, Anderson J . The role of claudins in determining paracellular charge selectivity. Proc Am Thorac Soc. 2005; 1(1):38-41. DOI: 10.1513/pats.2306013. View

Wu M . Endothelial focal adhesions and barrier function. J Physiol. 2005; 569(Pt 2):359-66. PMC: 1464245. DOI: 10.1113/jphysiol.2005.096537. View

Cohen J, Barkhof F, Comi G, Hartung H, Khatri B, Montalban X . Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med. 2010; 362(5):402-15. DOI: 10.1056/NEJMoa0907839. View

Xu M, Waters C, Hu C, Wysolmerski R, Vincent P, Minnear F . Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase. Am J Physiol Cell Physiol. 2007; 293(4):C1309-18. DOI: 10.1152/ajpcell.00014.2007. View

Dudek S, Chiang E, Camp S, Guo Y, Zhao J, Brown M . Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function. Mol Biol Cell. 2010; 21(22):4042-56. PMC: 2982111. DOI: 10.1091/mbc.E09-10-0876. View

Lee J, Zeng Q, Ozaki H, Wang L, Hand A, Hla T . Dual roles of tight junction-associated protein, zonula occludens-1, in sphingosine 1-phosphate-mediated endothelial chemotaxis and barrier integrity. J Biol Chem. 2006; 281(39):29190-200. DOI: 10.1074/jbc.M604310200. View

10.

Garcia J, Liu F, Verin A, Birukova A, Dechert M, Gerthoffer W . Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest. 2001; 108(5):689-701. PMC: 209379. DOI: 10.1172/JCI12450. View

11.

Boyle S, Michaud G, Schweitzer B, Predki P, Koleske A . A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation. Curr Biol. 2007; 17(5):445-51. DOI: 10.1016/j.cub.2007.01.057. View

12.

Romer L, Birukov K, Garcia J . Focal adhesions: paradigm for a signaling nexus. Circ Res. 2006; 98(5):606-16. DOI: 10.1161/01.RES.0000207408.31270.db. View

13.

Birukova A, Zagranichnaya T, Alekseeva E, Bokoch G, Birukov K . Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection. J Cell Physiol. 2007; 215(3):715-24. PMC: 3652875. DOI: 10.1002/jcp.21354. View

14.

Carmeliet P, Lampugnani M, Moons L, Breviario F, Compernolle V, Bono F . Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell. 1999; 98(2):147-57. DOI: 10.1016/s0092-8674(00)81010-7. View

15.

Neviani P, Santhanam R, Oaks J, Eiring A, Notari M, Blaser B . FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. J Clin Invest. 2007; 117(9):2408-21. PMC: 1950458. DOI: 10.1172/JCI31095. View

16.

Garcia J, Schaphorst K, Verin A, Vepa S, PATTERSON C, Natarajan V . Diperoxovanadate alters endothelial cell focal contacts and barrier function: role of tyrosine phosphorylation. J Appl Physiol (1985). 2000; 89(6):2333-43. DOI: 10.1152/jappl.2000.89.6.2333. View

17.

Mitra S, Hanson D, Schlaepfer D . Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol. 2005; 6(1):56-68. DOI: 10.1038/nrm1549. View

18.

Singleton P, Dudek S, Ma S, Garcia J . Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family. J Biol Chem. 2006; 281(45):34381-93. DOI: 10.1074/jbc.M603680200. View

19.

Bazzoni G, Dejana E . Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004; 84(3):869-901. DOI: 10.1152/physrev.00035.2003. View

20.

Wang W, DENTLER W, Borchardt R . VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol. 2000; 280(1):H434-40. DOI: 10.1152/ajpheart.2001.280.1.H434. View